Peru Lauds Sinopharm's COVID-19 Vaccine
Peru Lauds Sinopharm's COVID-19 Vaccine
BEIJING--August 30, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--According to Peru's Ministry of Health, China's Sinopharm vaccine has reduced Peru's COVID-19 mortality rate by 98% among those who received two doses. Only 5.2% of those vaccinated were later infected, and at least 9% were able to produce neutralizing antibodies.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects